A STAT News opinion piece warns that infectious diseases pose significant risks to astronauts on long-duration space missions, urging NASA to prioritize immunology research. The authors argue that the unique environment of spaceflight can weaken immune systems and promote microbial growth, making illness a major threat.
Current planning for missions to the Moon and Mars, under NASA's Artemis program, largely focuses on engineering challenges but overlooks biological vulnerabilities. Without dedicated studies on immune function and pathogen behavior in microgravity, astronauts could face preventable health crises far from Earth.
The piece highlights that space travel alters the human microbiome and increases antibiotic resistance in bacteria. These factors, combined with limited medical resources, could turn a minor infection into a life-threatening event for crews on months-long journeys.
Prioritizing immunology could lead to better countermeasures, such as advanced vaccines or real-time health monitoring systems. The authors call for integrating infectious disease specialists into mission planning teams to mitigate these overlooked hazards.
Critics might argue that budget constraints and technical hurdles already stretch NASA's resources, making new research priorities difficult to fund. However, the article stresses that failing to address immunology now could jeopardize crew safety and mission success.